Gastrointestinal Stromal Tumor
Therapeutic response
Precision oncology relationships for therapeutic response involving this cancer type.
| Organization(s) | Biomarker(s) | Cancer type | Therapy(ies) | |
|---|---|---|---|---|
| EMA (1) FDA (1) | PDGFRA p.D842V | Gastrointestinal Stromal Tumor | Avapritinib | |
| EMA (2) FDA (1) HSE (2) | CD117 + | Gastrointestinal Stromal Tumor | Imatinib | |
| FDA (1) | FIP1L1::PDGFRA | Gastrointestinal Stromal Tumor | Imatinib | |
| FDA (1) | HER2-positive | Gastrointestinal Stromal Tumor | Trastuzumab | |
| EMA (1) | MSI-H | Gastrointestinal Stromal Tumor | Pembrolizumab | |
| EMA (1) | dMMR | Gastrointestinal Stromal Tumor | Pembrolizumab |